E

Eurofins Viracor BioPharma Services Tech Stack

Contract research lab for drug development and clinical trial testing

Biotechnology Research Lenexa, Kansas 201–500 employees Founded 1983 Public Company

Eurofins Viracor BioPharma operates a contract research facility serving pharmaceutical developers across clinical trial phases, running 3,000+ validated assays on 40+ technology platforms (GC-MS, LC-MS, HPLC, cell culture, immunohistochemistry, and ELISA). The hiring surge is heavily research-driven (19 of 48 active roles), with production bottlenecks and regulatory compliance gaps appearing as near-term operational constraints.

Tech Stack 19 technologies

Core StackPython Microsoft Office Windows GC-MS LC-MS ICP-MS HPLC GCP ImageJ Oracle HCM Cloud Excel Word Visio Microsoft Project Adobe Acrobat Pro UPLC LIMS SDS-PAGE Google Docs

What Eurofins Viracor BioPharma Services Is Building

◆Challenges

Production bottlenecks
Client complaints resolution
Compliance with cpsia
Meeting regulatory certification requirements
Understanding degradation mechanisms
Reducing client escalations
Ensuring instrument readiness
Data gaps
Process inefficiencies
Ensuring product safety compliance

▲Active Projects

Disease relevant immunohistochemistry assays
Purification workflows
Cell culture studies
Crystallization process development
Dissolution methodology development
Degradation mechanism studies
Stability risk assessment
Method establishment and validation of multiplex elisas using ecl platforms
Participant recruitment outreach

Hiring Activity

Accelerating50 roles · 50 in 30d

Department

Research

19

Ops

12

Engineering

4

Support

3

Finance

2

Product

2

Sales

2

Healthcare

1

Seniority

Mid

18

Junior

16

Manager

6

Senior

5

Lead

2

Principal

1

Company intelligence

Find more companies like Eurofins Viracor BioPharma Services by tech stack, pain points and active projects

Get started free

About Eurofins Viracor BioPharma Services

Eurofins Viracor BioPharma is a contract research organization providing testing and assay development for pharmaceutical companies and contract research organizations advancing clinical trials. The company offers services spanning molecular infectious disease testing, vaccine safety and efficacy, immunogenicity, cell-based assays, allergy/hypersensitivity testing, and biomarker analysis across all major therapeutic categories. Founded in 1983 and headquartered in Lenexa, Kansas, the firm maintains a 200–500-person operation with active hiring in the United States and Peru. Core projects center on assay method validation, cell culture workflows, and process development (crystallization, dissolution, degradation studies); operational challenges include managing production throughput, reducing client escalations, and meeting evolving regulatory and safety compliance requirements.

HeadquartersLenexa, Kansas

Company Size201–500 employees

Founded1983

Hiring MarketsUnited States, Peru

Frequently Asked Questions

What does Eurofins Viracor BioPharma test for?

The company provides 3,000+ validated assays and custom assay development for drug efficacy, safety, and immunogenicity across clinical trials. Services include molecular infectious disease testing, vaccine safety, immunogenicity, cell-based assays, allergy/hypersensitivity, and biomarker analysis.

What technology platforms does Eurofins Viracor use?

The lab operates 40+ platforms including GC-MS, LC-MS, ICP-MS, HPLC, UPLC, SDS-PAGE, cell culture, immunohistochemistry, and ELISA. Infrastructure also includes GCP, LIMS, Oracle HCM, and Microsoft Office suite.